How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort study

Internal Medicine Journal

Volumn 43, Issue 1, 2013, Pages 66-72

  Lassere, M N ^a,b   Rappo, J ^b   Portek, I J ^c   Sturgess, A ^a,b   Edmonds, J P ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c Combined Rheumatology Practice ^*  (Australia)

Author keywords

Cohort; Methotrexate; Mortality; Radiograph; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; DEATH CERTIFICATE; DISEASE ACTIVITY; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUSTRALIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DEATH CERTIFICATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASMS;

EID: 84872583955     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2012.02727.x     Document Type: Article

References (21)

1. Cobb S, Anderson F, Bauer M. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953; 249: 553-556.
2. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26: S35-61.
3. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS etal. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
4. Van Der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993; 20: 579-581.
5. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977; 18: 481-491.
6. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982; 9: 789-793.
7. Australian Institute of Health and Welfare. National Death Index. [cited 2012 Feb 16]. Available from URL: http://www.aihw.gov.au/national-death-index/.
8. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008; 59: 1690-1697.
9. Meune C, Touze E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2009; 48: 1309-1313.
10. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol 1984; 11: 158-161.
11. Reah TG. The prognosis of rheumatoid arthritis (185 patients followed up over 13 years). Proc R Soc Med 1963; 56: 813-817.
12. Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum 2001; 44: 2746-2749.
13. Selvin S. Statistical Analysis of Epidemiologic Data. New York: Oxford University Press, Inc; 1991.
14. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar R. 1958 revision of the diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175-176.
15. Van der Heijde D, Klareskog L, Landewé R, Bruyn GAW, Cantagrel A, Durez P etal. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 2007; 56: 3928-3939.
16. Buchbinder R, March L, Lassere M, Briggs AM, Portek I, Reid C etal. Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association database. Intern Med J 2007; 37: 591-600.
17. Jacobsson LTH, Turesson C, Nilsson JA, Petersson IF, Lindqvist E, Saxne T etal. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 670-675.
18. Lunt M, Watson KD, Dixon WG, British Society for Rheumatology Biologics Register Control Centre Consortium, Symmons DPM, Hyrich KL; British Society for Rheumatology Biologics Register. No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2010; 62: 3145-3153.
19. Messite J, Stellman SD. Accuracy of death certificate completion: the need for formalized physician training. JAMA 1996; 275: 794-796.
20. Johansson LA, Bjorkenstam C, Westerling R. Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1, 094 deaths in Sweden during 1995. J Clin Epidemiol 2009; 62: 1202-1209.
21. Boyle CA, Dobson AJ. The accuracy of hospital records and death certificates for acute myocardial infarction. Aust N Z J Med 1995; 25: 316-323.